Insider Trading Activity GenMark Diagnostics, Inc. (NASDAQ:GNMK) – Insider Sold 1,629 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

Hany Massarany , Insider of GenMark Diagnostics, Inc. (NASDAQ:GNMK) reportedly Sold 1,629 shares of the company’s stock at an average price of 10.33 for a total transaction amount of $16,827.57 SEC Form

Insider Trading History For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

On 7/1/2013 Jon Faiz Kayyem, SVP, sold 6,000 with an average share price of $10.40 per share and the total transaction amounting to $62,400.00.View SEC Filing

On 8/20/2013 Jon Faiz Kayyem, SVP, sold 1,310 with an average share price of $10.15 per share and the total transaction amounting to $13,296.50.View SEC Filing

On 9/3/2013 Jon Faiz Kayyem, SVP, sold 1,545 with an average share price of $11.60 per share and the total transaction amounting to $17,922.00.View SEC Filing

On 9/3/2013 Hany Massarany, CEO, sold 2,354 with an average share price of $11.60 per share and the total transaction amounting to $27,306.40.View SEC Filing

On 9/4/2013 Jeffrey Alan Hawkins, SVP, sold 1,890 with an average share price of $11.60 per share and the total transaction amounting to $21,924.00.View SEC Filing

On 10/1/2013 Jon Faiz Kayyem, SVP, sold 6,000 with an average share price of $12.14 per share and the total transaction amounting to $72,840.00.View SEC Filing

On 10/9/2013 Hany Massarany, CEO, sold 3,925 with an average share price of $12.05 per share and the total transaction amounting to $47,296.25.View SEC Filing

Analyst Ratings For GenMark Diagnostics, Inc. (NASDAQ:GNMK)
These are 4 Buy Ratings .
The current consensus rating for GenMark Diagnostics, Inc. (NASDAQ:GNMK) is Buy (Score: 3.00) with a consensus target price of $17.00 , a potential (53.99% upside)

Analyst Ratings History For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

On 2/26/2016 Raymond James Financial, Inc. Lower Price Target of rating Outperform with a price target of $9.00 to $7.25
On 7/29/2016 J P Morgan Chase & Co Boost Price Target of rating Overweight with a price target of $10.00 to $13.00
On 5/17/2017 BTIG Research Reiterated Rating Buy with a price target of $17.00
On 6/12/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $17.00
On 6/13/2017 Needham & Company LLC Boost Price Target of rating Buy to Buy with a price target of $16.00 to $17.00
On 8/2/2017 Cowen and Company Reiterated Rating Outperform with a price target of $17.00

Recent Trading Activity for GenMark Diagnostics, Inc. (NASDAQ:GNMK)
Shares of GenMark Diagnostics, Inc. closed the previous trading session at 11.04 up +0.40 3.76% with 795,432 shares trading hands.